BACKGROUND: Electroconvulsive shock (ECS), also known as an electroconvulsive therapy (ECT), is an effective and safe treatment for neuropsychiatric disorders including pharmacoresistant major depressive disorder. Previous research in animal models suggests ECS efficacy is achieved by Gadd45b-mediated increases in adult hippocampal neurogenesis. OBJECTIVE/HYPOTHESIS: The present study aims to delineate the role of Gadd45b in mediating proliferation of neural stem cell types including quiescent radial glia-like (RGL) and amplifying non-radial glia-like (non-RGL) neural precursors following ECS. METHODS: RGL and non-RGL neural stem cell populations defined by co-localization of MCM2+ and nestin+ cells and morphologically by the presence of radial processes were stereologically analyzed. RESULTS: ECS increased hippocampal density of both quiescent RGLs and amplifying non-RGLs. CONCLUSIONS: Gadd45b mediates the action of ECS-induced proliferation through activation of quiescent neural stem cells.
BACKGROUND:Electroconvulsive shock (ECS), also known as an electroconvulsive therapy (ECT), is an effective and safe treatment for neuropsychiatric disorders including pharmacoresistant major depressive disorder. Previous research in animal models suggests ECS efficacy is achieved by Gadd45b-mediated increases in adult hippocampal neurogenesis. OBJECTIVE/HYPOTHESIS: The present study aims to delineate the role of Gadd45b in mediating proliferation of neural stem cell types including quiescent radial glia-like (RGL) and amplifying non-radial glia-like (non-RGL) neural precursors following ECS. METHODS:RGL and non-RGL neural stem cell populations defined by co-localization of MCM2+ and nestin+ cells and morphologically by the presence of radial processes were stereologically analyzed. RESULTS: ECS increased hippocampal density of both quiescent RGLs and amplifying non-RGLs. CONCLUSIONS:Gadd45b mediates the action of ECS-induced proliferation through activation of quiescent neural stem cells.
Authors: S Yoshimura; Y Takagi; J Harada; T Teramoto; S S Thomas; C Waeber; J C Bakowska; X O Breakefield; M A Moskowitz Journal: Proc Natl Acad Sci U S A Date: 2001-04-24 Impact factor: 11.205
Authors: Charles H Kellner; Robert M Greenberg; James W Murrough; Ethan O Bryson; Mimi C Briggs; Rosa M Pasculli Journal: Am J Psychiatry Date: 2012-12 Impact factor: 18.112
Authors: James W Murrough; Dan V Iosifescu; Lee C Chang; Rayan K Al Jurdi; Charles E Green; Andrew M Perez; Syed Iqbal; Sarah Pillemer; Alexandra Foulkes; Asim Shah; Dennis S Charney; Sanjay J Mathew Journal: Am J Psychiatry Date: 2013-10 Impact factor: 18.112
Authors: Mi-Hyeon Jang; Michael A Bonaguidi; Yasuji Kitabatake; Jiaqi Sun; Juan Song; Eunchai Kang; Heechul Jun; Chun Zhong; Yijing Su; Junjie U Guo; Marie Xun Wang; Kurt A Sailor; Ju-Young Kim; Yuan Gao; Kimberly M Christian; Guo-li Ming; Hongjun Song Journal: Cell Stem Cell Date: 2013-02-07 Impact factor: 24.633
Authors: Torsten M Madsen; Samuel S Newton; Molly E Eaton; David S Russell; Ronald S Duman Journal: Biol Psychiatry Date: 2003-11-15 Impact factor: 13.382
Authors: Rosalyn J Moran; Matthew W Jones; Anthony J Blockeel; Rick A Adams; Klaas E Stephan; Karl J Friston Journal: Neuropsychopharmacology Date: 2014-07-23 Impact factor: 7.853
Authors: G Quesseveur; D J David; M C Gaillard; P Pla; M V Wu; H T Nguyen; V Nicolas; G Auregan; I David; A Dranovsky; P Hantraye; R Hen; A M Gardier; N Déglon; B P Guiard Journal: Transl Psychiatry Date: 2013-04-30 Impact factor: 6.222
Authors: Teresa Muro-García; Soraya Martín-Suárez; Nelson Espinosa; Roberto Valcárcel-Martín; Ainhoa Marinas; Laura Zaldumbide; Lara Galbarriatu; Amanda Sierra; Pablo Fuentealba; Juan Manuel Encinas Journal: Front Cell Dev Biol Date: 2019-08-20